Different Molecular Subtypes of Peripheral T-cell Lymphoma, a Real-world Registry Study. (TRUST Study)

Status: Recruiting
Location: See all (6) locations...
Intervention Type: Genetic
Study Type: Observational
SUMMARY

A multi-center, prospective, registry study to analyze the clinical characteristics and prognosis of different molecular subtypes of peripheral T-cell lymphoma.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Patients diagnosed with peripheral T-cell lymphoma (PTCL) by histopathology from June 2023 to December 2026 and detected by gene sequencing (NGS) with different molecular subtypes.

• Patients diagnosed with PTCL by histopathology from January 2023 to June 2023 and NGS detection can be performed if there is tumor tissue.

• Informed consented

• Age ≥ 18 years

Locations
Other Locations
China
Peking University People's Hospital
RECRUITING
Beijing
Henan Cancer Hospital
RECRUITING
Henan
Affiliated Drum Tower Hospital, Medical School of Nanjing University
RECRUITING
Nanjing
Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China
NOT_YET_RECRUITING
Shandong
Shanghai Institute of Hematology, Rui-Jin Hospital affiliated to Shanghai Jiao Tong University School of Medicine
RECRUITING
Shanghai
Department of Hematology, West China Hospital, Sichuan University, Chengdu, Sichuan, China
RECRUITING
Sichuan
Contact Information
Primary
Weili Zhao
zwl_trial@163.com
+862164370045
Backup
Pengpeng Xu
pengpeng_xu@126.com
+862164370045
Time Frame
Start Date: 2023-07-13
Estimated Completion Date: 2026-06-01
Participants
Target number of participants: 1000
Treatments
Gene mutation profile of PTCL
84-gene penal was targeted sequenced in 1000 PTCL patients to investigate their mutation profile and molecular subtypes.
Sponsors
Leads: Ruijin Hospital
Collaborators: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, RenJi Hospital, West China Hospital, Tianjin Medical University Cancer Institute and Hospital, Shandong Provincial Hospital

This content was sourced from clinicaltrials.gov